[stock-market-ticker symbols=" ^NYA;CRYPTO:BTC;CRYPTO:ETH;CRYPTO:USDT;CRYPTO:USDC;CRYPTO:BNB;CRYPTO:ADA;CRYPTO:XRP;CRYPTO:SOL;CRYPTO:DOGE " stockExchange="NYSENASDAQ" width="100%" transparentbackground=1 palette="financial-light"]

Get the latest news and updates on FINTECH.TV

Skye Bioscience’s Developing Treatment for Glaucoma

Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves.

Advertisement

Latest articles

Related articles